CD1D and neoplasm: Despite limited CD1d expression in most human tumors, tumor-associated macrophages (TAMs) in various cancers do express CD1d, allowing iNKT cells to either lyse (16) or remodel (17, 18) these TAMs to enhance antitumor responses.